Your Challenges Require Smart Solutions:

Coronavirus Update - LKF

Please find latest news down below.

In the light of the dynamic circumstances around the Coronavirus, LKF would like to reassure you that we are constantly monitoring the situation with the goal of maintaining uninterrupted shipments of our supplies to your clinical sites as well as biological specimens to LKF, while also protecting the health of our employees.

Although some countries have closed their borders the merchandise traffic is mainly still possible. Please always allow some time for a delivery as additional transit time may apply for shipments. Currently we are performing all supplies to the U.S. with FedEx. A Temporary Surcharge on all FedEx and TNT shipments due to restrictions in the global supply chain and limited cargo capacity does apply. The transport of manufacturing goods with Special Express via the country is possible with time delays due to the traffic. Additional costs for transports may apply. The possibilities for each transport need to be checked individually. Please get in contact with LKF if you need any support. The situation changes on a daily basis and there is no guarantee that the status that may apply today will apply the next days as well. We will try to keep you updated as soon as possible. In case of any questions please contact the project team via email (project(at) or phone (+49 4307 8276-0).

Please also view our Business Continuity Plan for an outbreak of infectious diseases.

Additionally please see here our press release from the BVMA regarding the system relevanz of CROs not only during COVID-19.


DHL: A service delay for some countries are in place:

World Courier: State of emergency has been extended in Japan, but the operations stay the same, due to further reductions in domestic flights longer transit times in Italy may apply; lockdown in India does apply until 3rd of May

Please find an updated Overview for Marken/DHL and World Courier here

For previously stated information regarding the Coronavirus (COVID-19) outbreak please follow here.

Relevante Links:

© 2024 GBA Group

Follow Us

  • linkedIn GBA Pharma
  • xing
  • GBA youtube
  • gba Instagram
ContactData PrivacyLegal NoticeTerms & ConditionsDisclosure
Phone Phone